Skip to main navigation Skip to search Skip to main content

Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries

  • Edward Burn
  • , Xintong Li
  • , Kristin Kostka
  • , Henry Morgan Stewart
  • , Christian Reich
  • , Sarah Seager
  • , Talita Duarte-Salles
  • , Sergio Fernandez-Bertolin
  • , María Aragón
  • , Carlen Reyes
  • , Eugenia Martinez-Hernandez
  • , Edelmira Marti
  • , Antonella Delmestri
  • , Katia Verhamme
  • , Peter Rijnbeek
  • , Scott Horban
  • , Daniel R. Morales
  • , Daniel Prieto-Alhambra*
  • *Corresponding author for this work
  • Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol)
  • University of Oxford
  • IQVIA Inc.
  • Northeastern University
  • University of Barcelona
  • University of Valencia
  • University of Dundee School of Medicine

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)
Original languageEnglish
Pages (from-to)495-510
Number of pages16
JournalPharmacoepidemiology and Drug Safety
Volume31
Issue number5
DOIs
Publication statusPublished - May 2022

Bibliographical note

ACKNOWLEDGEMENTS:
This study was funded by the European Medicines Agency in the form of a competitive tender (Lot ROC No EMA/2017/09/PE). The authors acknowledge Prof. Johan Van der Lei for the overall management of this research grant.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this